634 related articles for article (PubMed ID: 33730739)
21. Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis but not from ultraviolet radiation-induced apoptosis.
Kothny-Wilkes G; Kulms D; Luger TA; Kubin M; Schwarz T
J Biol Chem; 1999 Oct; 274(41):28916-21. PubMed ID: 10506136
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inhibitory protein.
Frese S; Brunner T; Gugger M; Uduehi A; Schmid RA
J Thorac Cardiovasc Surg; 2002 Jan; 123(1):168-74. PubMed ID: 11782771
[TBL] [Abstract][Full Text] [Related]
23. TRAIL-induced apoptosis and gene induction in HaCaT keratinocytes: differential contribution of TRAIL receptors 1 and 2.
Leverkus M; Sprick MR; Wachter T; Denk A; Bröcker EB; Walczak H; Neumann M
J Invest Dermatol; 2003 Jul; 121(1):149-55. PubMed ID: 12839575
[TBL] [Abstract][Full Text] [Related]
24. Camptothecin fails to induce apoptosis in tumor necrosis factor-alpha-treated HaCaT cells.
Sun J; Han J; Zhu Q; Li Z; Hu J
Pharmacology; 2012; 89(1-2):58-63. PubMed ID: 22301394
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the Effect of Gentian Violet on Apoptosis and Proliferation in Cutaneous T-Cell Lymphoma in an In Vitro Study.
Wu J; Wood GS
JAMA Dermatol; 2018 Oct; 154(10):1191-1198. PubMed ID: 30167641
[TBL] [Abstract][Full Text] [Related]
26. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility of the C2 canine mastocytoma cell line to the effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Elders RC; Baines SJ; Catchpole B
Vet Immunol Immunopathol; 2009 Jul; 130(1-2):11-6. PubMed ID: 19185923
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase inhibitor-induced sensitization to TNFalpha/TRAIL-mediated apoptosis in cervical carcinoma cells is dependent on HPV oncogene expression.
Darvas K; Rosenberger S; Brenner D; Fritsch C; Gmelin N; Krammer PH; Rösl F
Int J Cancer; 2010 Sep; 127(6):1384-92. PubMed ID: 20087862
[TBL] [Abstract][Full Text] [Related]
29. Trifloxystrobin induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in HaCaT, human keratinocyte cells.
Jang Y; Lee AY; Chang SH; Jeong SH; Park KH; Paik MK; Cho NJ; Kim JE; Cho MH
Drug Chem Toxicol; 2017 Jan; 40(1):67-73. PubMed ID: 27149887
[TBL] [Abstract][Full Text] [Related]
30. MG-132 treatment promotes TRAIL-mediated apoptosis in SEB-1 sebocytes.
Ji J; Zhou BR; Zhang RH; Li HM; Guo Q; Zhu J; Luo D
Life Sci; 2018 Oct; 210():150-157. PubMed ID: 30176247
[TBL] [Abstract][Full Text] [Related]
31. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2.
Diessenbacher P; Hupe M; Sprick MR; Kerstan A; Geserick P; Haas TL; Wachter T; Neumann M; Walczak H; Silke J; Leverkus M
J Invest Dermatol; 2008 May; 128(5):1134-47. PubMed ID: 17989734
[TBL] [Abstract][Full Text] [Related]
32. [Inhibitory effect of epidermal growth factor on apoptosis in HaCaT keratinocytes induced by TNF-alpha].
Liang PF; Huang XY; Chen BF; Jiang BM; Long JH; Zhang PH; Yang XH
Zhonghua Shao Shang Za Zhi; 2007 Aug; 23(4):284-7. PubMed ID: 18095554
[TBL] [Abstract][Full Text] [Related]
33. Quercetin-3-O-(2"-galloyl)-α-l-rhamnopyranoside prevents TRAIL-induced apoptosis in human keratinocytes by suppressing the caspase-8- and Bid-pathways and the mitochondrial pathway.
Kim YJ; Jung EB; Seo SJ; Park KH; Lee MW; Lee CS
Chem Biol Interact; 2013 Aug; 204(3):144-52. PubMed ID: 23711929
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.
Jaganathan J; Petit JH; Lazio BE; Singh SK; Chin LS
Neurosurg Focus; 2002 Sep; 13(3):ecp1. PubMed ID: 15844877
[TBL] [Abstract][Full Text] [Related]
35. TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways.
Song JH; Song DK; Pyrzynska B; Petruk KC; Van Meir EG; Hao C
Brain Pathol; 2003 Oct; 13(4):539-53. PubMed ID: 14655759
[TBL] [Abstract][Full Text] [Related]
36. Cooperative TRAIL production mediates IFNα/Smac mimetic-induced cell death in TNFα-resistant solid cancer cells.
Roesler S; Eckhardt I; Wolf S; Fulda S
Oncotarget; 2016 Jan; 7(4):3709-25. PubMed ID: 26788912
[TBL] [Abstract][Full Text] [Related]
37. Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation.
Leverkus M; Sprick MR; Wachter T; Mengling T; Baumann B; Serfling E; Bröcker EB; Goebeler M; Neumann M; Walczak H
Mol Cell Biol; 2003 Feb; 23(3):777-90. PubMed ID: 12529384
[TBL] [Abstract][Full Text] [Related]
38. Type I interferon and TNFalpha cooperate with type II interferon for TRAIL induction and triggering of apoptosis in SK-N-MC EWING tumor cells.
Abadie A; Besançon F; Wietzerbin J
Oncogene; 2004 Jun; 23(28):4911-20. PubMed ID: 15077162
[TBL] [Abstract][Full Text] [Related]
39. Etoposide-mediated sensitization of squamous cell carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced loss in mitochondrial membrane potential.
Itoh M; Noutomi T; Toyota H; Mizuguchi J
Oral Oncol; 2003 Apr; 39(3):269-76. PubMed ID: 12618199
[TBL] [Abstract][Full Text] [Related]
40. The platelet-activating factor receptor protects epidermal cells from tumor necrosis factor (TNF) alpha and TNF-related apoptosis-inducing ligand-induced apoptosis through an NF-kappa B-dependent process.
Southall MD; Isenberg JS; Nakshatri H; Yi Q; Pei Y; Spandau DF; Travers JB
J Biol Chem; 2001 Dec; 276(49):45548-54. PubMed ID: 11571293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
